| |
| Device | G5 Mobile Continuous Glucose Monitoring System |
| Generic Name | Sensor, glucose, invasive |
| Applicant | Dexcom, Inc. 6340 Sequence Dr. San Diego, CA 92121 |
| PMA Number | P120005 |
| Supplement Number | S087 |
| Date Received | 08/06/2020 |
| Decision Date | 09/03/2020 |
| Withdrawal Date | 03/20/2026 |
| Product Code |
MDS |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01514292
|
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval of the interim analysis for the post-approval study (PAS) protocol. |